News

Ovintiv price target lowered to $50 from $57 at Morgan Stanley
Morgan Stanley analyst Devin McDermott lowered the firm’s price target on Ovintiv (OVV) to $50 from $57 and keeps an Overweight rating on the ...
Morgan Stanley Remains a Buy on Ovintiv (OVV)
In a report released today, Devin McDermott from Morgan Stanley maintained a Buy rating on Ovintiv (OVV – Research Report), with a price target ...